Biktarvy, formally known as bictegravir, represents a potent single-tablet regimen for managing HIV infection. This medication unites three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by preventing the virus's ability to multiply within the body, remarkably lowering the viral quantity. For many indivi